Feasibility of tuberculosis treatment monitoring by video directly observed therapy: A binational pilot study

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 9, 2015, Pages 1057-1064

  Garfein, R S ^a   Collins, K ^a   Munoz F ^a   Moser, K ^b   Cerecer Callu, P ^c   Raab, F ^d   Rios, P ^e   Flick, A ^e   Zuniga M L ^f   Cuevas Mota, J ^a   Liang, K ^b   Rangel, G ^g   Burgos, J L ^a   Rodwell, T C ^a   Patrick, K ^d,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA COOPERATIVE EXTENSION   (United States)

^c Instituto de Servicios de Salud   (Mexico)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAN DIEGO STATE UNIVERSITY   (United States)

^g SECRETARÍA DE SALUD   (Mexico)

Author keywords

Cellular phone; Dot; Drug resistance; Medication adherence; Mhealth; US Mexico border

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEXICO; PATIENT MONITORING; PILOT STUDY; PRIORITY JOURNAL; PROGRAM FEASIBILITY; SHORT COURSE THERAPY; TELEMONITORING; TREATMENT DURATION; TUBERCULOSIS; UNITED STATES; VIDEO DIRECTLY OBSERVED THERAPY; VIDEORECORDING; ADOLESCENT; CALIFORNIA; COST BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FEASIBILITY STUDY; MIDDLE AGED; MOBILE PHONE; PROCEDURES; TELEMEDICINE; VERY ELDERLY; YOUNG ADULT;

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CALIFORNIA; CELL PHONES; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MEXICO; MIDDLE AGED; PILOT PROJECTS; TELEMEDICINE; TUBERCULOSIS; VIDEO RECORDING; YOUNG ADULT;

EID: 84939163518     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0923     Document Type: Article

References (18)

1. World Health Organization. Tuberculosis report 2013. Fact sheet no 104. Geneva, Switzerland: WHO, 2015 http://www.who.int/mediacentre/factsheets/fs104/en/Accessed May 2015.
2. Curry International Tuberculosis Center. Drug-resistant tuberculosis: A survival guide for clinicians, 2011. 2nd ed. Oakland, CA, USA: University of California San Francisco, 2011. http://www.currytbcenter.ucsf.edu/drtb/docs/MDRTB-book-2011.pdf. Accessed May 2015.
3. Centers for Disease Control and Prevention. Trends in tuberculosis, 2013 factsheet. Atlanta, GA, USA: CDC, 2013. http://www.cdc.gov/tb/publications/factsheets/statistics/tbtrends.htm. Accessed May 2015.
4. Secretaria de Salud, Jurisdiccion Sanitaria No. 2 Tijuana. Programa de Microbacteriosis TB y Lepra 2013. Plan de Accion para el manejo y acceso universal al dignostico y tratamiento de la tuberculosis y TB-MFR. Tijuana, Mexico: Jurisdicci on de Servicios de Salud No. II Tijuana, 2013.
5. US General Services Administration. San Ysidro Land Port of Entry. Washington DC, USA: GSA, 2014. http://www.gsa.gov/portal/content/104872. Accessed May 2015.
6. County of San Diego Health and Human Services Agency. Tuberculosis and refugee health. San Diego, CA, USA: County of San Diego Health and Human Services Agency, 2013. http://www.sdcounty.ca.gov/hhsa/programs/phs/documents/Factsheet-2013-final-3-13-14.pdf. Accessed May 2015.
7. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
8. Centers for Disease Control and Prevention. Ten great public health achievements-worldwide, 2001-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 814-818.
9. World Health Organization. The Stop TB Strategy: building on and enhancing DOTS to meet the TB-related Millenium Development Goals. WHO/HTM/TB/2006.368. Geneva, Switzerland: WHO, 2006. http://whqlibdoc.who.int/hq/2006/WHO-HTM-STB-2006.368-eng.pdf. Accessed May 2015.
10. Chaulk C P, Kazandjian V A. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA 1998; 279: 943-948.
11. Pasipanodya J G, Gumbo T. A meta-analysis of selfadministered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis 2013; 57: 21-31.
12. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. CochraneDatabase Syst Rev 2007; (4): CD003343.
13. Floyd K, Pantoja A. Financial resources required for tuberculosis control to achieve global targets set for 2015. Bull World Health Organ 2008; 86: 568-576.
14. World Health Organization. MHealth: new horizons for health through mobile technologies. WHO Global Observatory for eHealth Series Vol 3. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789241564250-eng.pdf?ua=1. Accessed May 2015.
15. Hoffman J A, Cunningham J R, Suleh A J, et al. Mobile direct observation treatment for tuberculosis patients: A technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med 2010; 39: 78-80.
16. Denkinger C M, Grenier J, Stratis A K, Akkihal A, Pant-Pai N, Pai M. Mobile health to improve tuberculosis care and control: A call worth making [Review]. Int J Tuberc Lung Dis 2013; 17: 719-727.
17. Garfein R S, Patrick K, Moser K, et al.Mobile phone-based video directly observed therapy for tuberculosis. Paper presented at: MHealth Summit, 8-10November, 2010, Washington, DC, USA.
18. DeMaio J, Schwartz L, Cooley P, Tice A. The application of telemedicine technology to a directly observed therapy program for tuberculosis: A pilot project. Clin Infect Dis 2001; 33: 2082-2084.